High and intermediate risk prostate cancer treated with three-dimensional computed tomography-guided brachytherapy: 2-8-year follow-up.

This publication has 19 references indexed in Scilit:

• Three-dimensional computed tomography-guided monotherapeutic pararectal brachytherapy of prostate cancer with seminal vesicle invasion
  Radiotherapy and Oncology, 2001
• Subset analysis of RTOG 85-31 and 86-10 indicates an advantage for long-term vs. short-term adjuvant hormones for patients with locally advanced nonmetastatic prostate cancer treated with radiation therapy
  International Journal of Radiation Oncology*Biology*Physics, 2001
• High- and Low-Risk Prostate Cancer Treated with 3D CT-Guided Brachytherapy: 1-to 5-Year Follow-up
  Journal of Endourology, 2000
• Optimal radiotherapy for prostate cancer: predictions for conventional external beam, imrt, and brachytherapy from radiobiologic models
  International Journal of Radiation Oncology*Biology*Physics, 2000
• Biochemical Outcome After Radical Prostatectomy, External Beam Radiation Therapy, or Interstitial Radiation Therapy for Clinically Localized Prostate Cancer
  JAMA, 1998
• THREE-DIMENSIONAL STEREOTACTIC POSTERIOR ISCHIORECTAL SPACE COMPUTERIZED TOMOGRAPHY GUIDED BRACHYTHERAPY OF PROSTATE CANCER: A PRELIMINARY REPORT
  Journal of Urology, 1998
• Prostate cancer patient subsets showing improved bNED control with adjuvant androgen deprivation
  International Journal of Radiation Oncology*Biology*Physics, 1997
• Improved Survival in Patients with Locally Advanced Prostate Cancer Treated with Radiotherapy and Goserelin
  New England Journal of Medicine, 1997
• Prediction of Progression Following Radical Prostatectomy
  The American Journal of Surgical Pathology, 1996
• Nonparametric Estimation from Incomplete Observations
  Journal of the American Statistical Association, 1958